Advice Page

< Return to Search Results

Drug Details

Drug Number: 533/09
Drug Name: adalimumab (Humira)
Drug Manufacturer: Abbott Laboratories
BNF Category: Musculoskeletal and joint diseases
Submission type : Abbreviated Submission
Date Advice Issued: 9 February 2009
Indication: Active polyarticular juvenile idiopathic arthritis in adolescents

Drug Advice

adalimumab (Humira)

Press Statement

Read the press statement

Minutes

Read the minutes

Notes

< Return to Search Results

Other SMC Advice for this Drug

There is currently no other SMC advice for this product







Help on how to improve your search.